Sequencing the two barcode forms separates reporter output from construct representation. Barcode RNA reflects transcripts produced after a regulatory sequence acts, whereas barcode DNA indicates how much of the corresponding construct is present in the assay. Comparing these measurements helps quantify activity relative to representation, so differences are less likely to reflect unequal construct abundance alone.
A unique barcode creates a compact identifier for each tested sequence, allowing many constructs to be analyzed together by sequencing. The barcode connects a sequence’s identity to its RNA and DNA counts. This multiplexed design supports comparisons among thousands of candidate elements, genetic variants, or synthetic sequences within the same experimental framework.
MPRA can test how candidate enhancers, promoters, transcription-factor binding sites, and synthetic regulatory sequences influence reporter expression. By comparing barcode-based activity across designed sequences or genetic variants, investigators can identify sequence features associated with stronger or weaker transcription. These measurements provide a systematic way to examine regulatory logic within noncoding DNA.
An experiment begins by cloning selected regulatory sequences upstream of a reporter gene and assigning each construct a unique DNA barcode. The constructs are introduced into cells, after which researchers sequence barcode DNA and barcode RNA. They then compare RNA output with DNA representation to estimate the regulatory activity associated with each sequence.
Researchers can compare reporter activity for alternative versions of a sequence to determine whether a genetic variant changes regulatory output. When variants produce different activity measurements, the results identify possible effects on transcriptional control. These comparisons help connect noncoding mutations with biological traits or disease and prioritize regulatory sequences for further investigation.
Because many elements are measured simultaneously, the assay can reveal patterns across regulatory sequences rather than focusing on one candidate at a time. Activity measurements can show which sequence features correspond to transcriptional differences and support systematic analysis of noncoding genome function. This makes the approach useful for studying natural variants and engineered regulatory sequences in biology.